ES8606293A1 - Un procedimiento para la preparacion de derivados de hidan- toina - Google Patents

Un procedimiento para la preparacion de derivados de hidan- toina

Info

Publication number
ES8606293A1
ES8606293A1 ES548960A ES548960A ES8606293A1 ES 8606293 A1 ES8606293 A1 ES 8606293A1 ES 548960 A ES548960 A ES 548960A ES 548960 A ES548960 A ES 548960A ES 8606293 A1 ES8606293 A1 ES 8606293A1
Authority
ES
Spain
Prior art keywords
chroman
imidazolidine
spiro
diones
antiarrhythmic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES548960A
Other languages
English (en)
Other versions
ES548960A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of ES8606293A1 publication Critical patent/ES8606293A1/es
Publication of ES548960A0 publication Critical patent/ES548960A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

METODO DE OBTENCION DE DERIVADOS DE HIDANTOINA Y SUS SALES DE FORMULA (I) DONDE X1 Y X2 SON IGUALES O DIFERENTES PUDIENDO SER HIDROGENO, HALOGENO, ALQUILO INFERIOR, ALCOXI INFERIOR O NITRO, O BIEN JUNTOS FORMAN UN GRUPO ALQUILENDIOXI; R1 Y R2 SON IGUALES O DIFERENTES Y REPRESENTAN HIDROGENO, ALQUILO INFERIOR, O BIEN UNIDOS FORMAN UNGRUPO CICLOALQUILO; N TOMA LOS VALORES DE 2 A 7 Y Z REPRESENTA UNA AMINA TERCIARIA O BIEN UN GRUPO PIPERIDIL DOBLEMENTE SUSTITUIDO EN POSICION 3 POR RADICALES, O TAMBIEN UN GRUPO PIPERIDIL CON UN HIDROXI EN POSICION 2. CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) DONDE X1, X2, R1 Y R2 TIENEN EL SIGNIFICADO ANTERIOR, CON UN HALURO DE ALQUILAMINA. DE UTILIZACION FARMACOLOGICA POR SU ACTIVIDAD ANTI-ARRITMICA.
ES548960A 1984-01-30 1985-11-15 Un procedimiento para la preparacion de derivados de hidan- toina Expired ES8606293A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59013442A JPS60158190A (ja) 1984-01-30 1984-01-30 ヒダントイン誘導体およびその製法ならびにそれを含有する医薬

Publications (2)

Publication Number Publication Date
ES8606293A1 true ES8606293A1 (es) 1986-04-16
ES548960A0 ES548960A0 (es) 1986-04-16

Family

ID=11833246

Family Applications (2)

Application Number Title Priority Date Filing Date
ES539942A Expired ES8605523A1 (es) 1984-01-30 1985-01-29 Un procedimiento para la preparacion de derivados de hidantoina.
ES548960A Expired ES8606293A1 (es) 1984-01-30 1985-11-15 Un procedimiento para la preparacion de derivados de hidan- toina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES539942A Expired ES8605523A1 (es) 1984-01-30 1985-01-29 Un procedimiento para la preparacion de derivados de hidantoina.

Country Status (23)

Country Link
US (1) US4650798A (es)
JP (1) JPS60158190A (es)
KR (1) KR870001681B1 (es)
AU (1) AU585207B2 (es)
BE (1) BE901591A (es)
CA (1) CA1249271A (es)
CH (1) CH662354A5 (es)
DE (1) DE3503074A1 (es)
DK (1) DK158668C (es)
ES (2) ES8605523A1 (es)
FI (1) FI83873C (es)
FR (1) FR2558835B1 (es)
GB (1) GB2155466B (es)
HU (1) HU194885B (es)
IE (1) IE850136L (es)
IT (1) IT1184144B (es)
MX (1) MX160579A (es)
NL (1) NL8500248A (es)
NZ (1) NZ210979A (es)
PH (1) PH21920A (es)
SE (1) SE462849B (es)
SU (3) SU1468424A3 (es)
ZA (1) ZA85655B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2708507B2 (ja) * 1988-04-07 1998-02-04 株式会社三和化学研究所 （ｄ）‐６‐フルオロ‐２，３‐ジヒドロ‐２’，５’‐ジオキソ‐スピロ［４Ｈ‐１‐ベンゾピラン‐４，４’‐イミダゾリジン］‐２‐カルボキサミド誘導体、これらの製法及び用途
JPH0276882A (ja) * 1988-06-20 1990-03-16 Eisai Co Ltd 光学活性ヒダントイン誘導体
IL96507A0 (en) * 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
US5206240A (en) * 1989-12-08 1993-04-27 Merck & Co., Inc. Nitrogen-containing spirocycles
GEP20001968B (en) * 1992-01-21 2000-03-05 Glaxo Spa Arilthio Compounds as Antibacterial and Antiviral Agents
US5382587A (en) * 1993-06-30 1995-01-17 Merck & Co., Inc. Spirocycles
US5403846A (en) * 1993-11-22 1995-04-04 Merck & Co., Inc. Spirocycles
US5439914A (en) * 1994-02-18 1995-08-08 Merck & Co., Inc. Spirocycles
GB2355264A (en) * 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2455046A1 (fr) * 1979-04-25 1980-11-21 Science Union & Cie Nouvelles hydantoines, leur procede de preparation et leur emploi comme medicament

Also Published As

Publication number Publication date
SE462849B (sv) 1990-09-10
US4650798A (en) 1987-03-17
HUT38646A (en) 1986-06-30
FR2558835B1 (fr) 1990-05-18
IT8519296A0 (it) 1985-01-30
FI850302A0 (fi) 1985-01-23
BE901591A (fr) 1985-07-29
SU1445559A3 (ru) 1988-12-15
FI850302L (fi) 1985-07-31
PH21920A (en) 1988-04-08
FI83873C (fi) 1991-09-10
IE850136L (en) 1985-07-30
DK39585D0 (da) 1985-01-29
GB2155466A (en) 1985-09-25
KR850005442A (ko) 1985-08-26
FR2558835A1 (fr) 1985-08-02
SU1468424A3 (ru) 1989-03-23
ES8605523A1 (es) 1986-03-16
ZA85655B (en) 1985-08-28
FI83873B (fi) 1991-05-31
SU1609453A3 (ru) 1990-11-23
AU585207B2 (en) 1989-06-15
SE8500387D0 (sv) 1985-01-28
GB8502308D0 (en) 1985-02-27
AU3806285A (en) 1985-08-08
DK39585A (da) 1985-07-31
NZ210979A (en) 1987-05-29
DK158668C (da) 1990-11-26
CH662354A5 (fr) 1987-09-30
ES539942A0 (es) 1986-03-16
DK158668B (da) 1990-07-02
JPS60158190A (ja) 1985-08-19
GB2155466B (en) 1987-10-07
JPH0441149B2 (es) 1992-07-07
DE3503074A1 (de) 1985-08-08
HU194885B (en) 1988-03-28
CA1249271A (en) 1989-01-24
IT1184144B (it) 1987-10-22
SE8500387L (sv) 1985-07-31
NL8500248A (nl) 1985-08-16
MX160579A (es) 1990-03-27
KR870001681B1 (ko) 1987-09-22
ES548960A0 (es) 1986-04-16

Similar Documents

Publication Publication Date Title
ES470070A1 (es) Un procedimiento para preparar el isomero dextrogiro de un compuesto de espiro hidantoina asimetrica
IE790088L (en) Thienohydantoin derivatives
AU5064785A (en) Preparing 5,6-CIS-1alpha-hydroxy vitamin D compounds
AU3935785A (en) Apparat och forfarande for registrering av bakteriefore-komst,speciellt under faltmassiga forhallanden
ES8606293A1 (es) Un procedimiento para la preparacion de derivados de hidan- toina
ZA901601B (en) (3-(c16-c18)-alkanesulphinyl-and-sulphonyl-2-methoxy-methylpropyl)-(2-trimethylammonioethyl)phosphates
AU571179B2 (en) Azirino(2',3'3,4)-pyrrolo (1,2-alpha) indole 4,7-dione (mitosane) derivatives
AU7170387A (en) 1,2,4-triazolo-(1,5a) pyrimidine -2- sulfonyl derivatives
YU162789A (en) 2-aza-4-(alcoxycarbonyl) spiro/4,5/decan-3-ones
AU3097789A (en) Benzofuro(3,2-c)quinoline compounds
GB8411794D0 (en) 1alpha,25 dihydroxylated vitamin d2 compounds
PT76552B (en) Process for preparing spiro-(fluorofluoren-9,4'-imidazolidine)-2',5'-diones and spiro-(difluoro-fluoren-9,4'-imidazolidine)-2,5'-diones
AU2773184A (en) Spiro(imidazolidine-4,3:-indoline) derivatives
IL71656A (en) 8-substituted 4s-6-fluoro-spiro(chroman-4,4'imidazolidine)-2',5'-diones
HRP931046A2 (en) New phospholipid derivatives
AU1383883A (en) Spiro (imidazolidine-4,3'-indoline) 2,2',5-triones
HUT42075A (en) Process for producing 2,2-comma above-bi/1h-imidazol/ derivatives
AU556487B2 (en) Antiallergic 4h-furo(3,2-beta) indoles
EP0251126A3 (en) 1,7-substituted heptyne-2-ones
AU588467B2 (en) Novel therapeutic agent for gastritis
AU5922786A (en) Process for producing 6,6'-dihydroxy-3,3,3',3'-tetramethyl- 1,1'-spirobiidane
ZA865148B (en) Preparation of 4,5-dihydrodithieno(3,4-b:3',4'-e)azepine-5,9-dione
AU5034885A (en) 3,4-dihydro-2h-naphtho (1,2-b) pyran derivatives
PT80882B (en) 4-substituted-1,2,4,6-thiatrizine derivatives
AU3934585A (en) Montage-einschubkasten mit vorderen rahmungsblenden und leerkasten, fur fenster- und turoffnungen

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506